Sequential changes in autonomic regulation of cardiac myocytes after in vivo endotoxin injection in rat

Am J Respir Crit Care Med. 1999 Oct;160(4):1196-204. doi: 10.1164/ajrccm.160.4.9808149.

Abstract

We report that in vivo injection of endotoxin (EDTX, 6 mg. kg(-)(1)) induces cardiovascular alterations in rats that closely mimic the clinical situation, as assessed by in vivo hemodynamic measurements in anesthetized and conscious, chronically instrumented animals. The patch-clamp technique was used to characterize the L-type calcium current (I(Ca)) and its autonomic regulation in isolated cardiac myocytes. The density of I(Ca) progressively decreased at 12 and 36 h after EDTX injection. However, the dihydropyridine (+/-)Bay K 8644 (100 nM) enhanced I(Ca) to levels similar to those in control and EDTX-treated myocytes. In addition, the net stimulatory effect of a beta-adrenergic agonist (isoproterenol) on I(Ca) was increased 12 h after EDTX injection. This change in the beta-adrenergic effect declined 24 h later. The potentiation in the beta-adrenergic stimulation of I(Ca) was mimicked by L858051 (10 microM), a direct activator of adenylyl cyclase, but not by IBMX (200 microM), a phosphodiesterase inhibitor. Besides, the antiadrenergic effect of acetylcholine on I(Ca) was unchanged 12 h after EDTX injection, but increased 36 h after EDTX injection. These results support the hypothesis that time-dependent changes in the adenylyl cyclase pathway in cardiac myocytes may contribute, via the autonomic regulation of I(Ca), to the severity of myocardial dysfunction during sepsis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester / pharmacology
  • Acetylcholine / pharmacology
  • Acetylcholine / physiology
  • Adenylyl Cyclases / metabolism
  • Adrenergic Antagonists / pharmacology
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Autonomic Nervous System / physiology*
  • Calcium Channel Agonists / pharmacology
  • Calcium Channels, L-Type / metabolism
  • Colforsin / analogs & derivatives
  • Colforsin / pharmacology
  • Diterpenes
  • Electrophysiology
  • Endotoxemia / physiopathology
  • Endotoxins / administration & dosage
  • Endotoxins / pharmacology*
  • Enzyme Activators / pharmacology
  • Escherichia coli
  • Heart / innervation*
  • Heart / physiology
  • Hemodynamics
  • In Vitro Techniques
  • Injections, Intravenous
  • Isoproterenol / pharmacology
  • Male
  • Myocardium / cytology*
  • Myocardium / metabolism
  • Patch-Clamp Techniques
  • Phosphodiesterase Inhibitors / pharmacology
  • Rats
  • Sepsis / physiopathology

Substances

  • Adrenergic Antagonists
  • Adrenergic beta-Agonists
  • Calcium Channel Agonists
  • Calcium Channels, L-Type
  • Diterpenes
  • Endotoxins
  • Enzyme Activators
  • Phosphodiesterase Inhibitors
  • L 858051
  • Colforsin
  • 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
  • Adenylyl Cyclases
  • Isoproterenol
  • Acetylcholine
  • 1-Methyl-3-isobutylxanthine